BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1525757)

  • 1. The use of the major anoxic stress response protein P34, the K isozyme of lactate dehydrogenase, and carcinoembryonic antigen in the follow-up of patients with colorectal adenocarcinoma.
    Petrelli NJ; Hanna S; Rodriguez-Bigas M; Anderson G
    Cancer; 1992 Oct; 70(7):1834-7. PubMed ID: 1525757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
    Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
    Fernandes LC; Kim SB; Saad SS; Matos D
    World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
    J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered immunoglobulin A (IgA-1) levels in patients with advanced colorectal adenocarcinoma presenting with normal preoperative levels of carcinoembryonic antigen (CEA).
    Petrelli NJ; Cajucom CC; Rodriguez-Bigas M; Henslee J; Bhargava A
    Surg Oncol; 1993; 2(1):19-23. PubMed ID: 7504559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of carcinoembryonic antigen as a marker for colorectal liver metastases.
    Jones C; Badger SA; Epanomeratikis E; McKie LD; Diamond T; Taylor MA
    Br J Biomed Sci; 2013; 70(2):47-50. PubMed ID: 23888604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer in young patients: characteristics and outcome.
    Alici S; Aykan NF; Sakar B; Bulutlar G; Kaytan E; Topuz E
    Tohoku J Exp Med; 2003 Feb; 199(2):85-93. PubMed ID: 12705353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on carcinoembryonic antigen (CEA), lactate dehydrogenase (LDH), and LDH isozymes in the tissue of colorectal carcinoma].
    Ono S
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):336-48. PubMed ID: 6325865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen.
    He WZ; Rong YM; Jiang C; Liao FX; Yin CX; Guo GF; Qiu HJ; Zhang B; Xia LP
    Chin J Cancer; 2016 Jun; 35(1):58. PubMed ID: 27357402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of determination of C reactive protein (CRP), carcinoembryonic antigen (CEA) and lactic dehydrogenase (LDH) in colorectal cancer].
    Abaza H; Ghanem A; Jmal A; Boussen H; Harzallah L; Rahal K; Guemira F
    Tunis Med; 2010 Jun; 88(6):409-13. PubMed ID: 20517851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
    Buccheri G; Ferrigno D;
    Lung Cancer; 2000 Oct; 30(1):37-49. PubMed ID: 11008008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA15.3, CEA and LDH in dogs with malignant mammary tumors.
    Campos LC; Lavalle GE; Estrela-Lima A; Melgaço de Faria JC; Guimarães JE; Dutra ÁP; Ferreira E; de Sousa LP; Rabelo ÉM; Vieira da Costa AF; Cassali GD
    J Vet Intern Med; 2012; 26(6):1383-8. PubMed ID: 23113715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplained increases in serum carcinoembryonic antigen levels in colorectal cancer patients during the postoperative follow-up period: an analysis of its incidence and longitudinal pattern.
    Nozawa H; Yokota Y; Emoto S; Yokoyama Y; Sasaki K; Murono K; Abe S; Sonoda H; Shinagawa T; Ishihara S
    Ann Med; 2023; 55(2):2246997. PubMed ID: 37963211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.